This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
Personal psychedelic use may be common among psychedelic therapists
Whether personal use of psychedelics is appropriate among psychedelic therapists, a new study finds that it may be common. The study is published in Psychedelic Medicine.
Experiential learning is common in psychotherapy. Psychedelic therapy is a practice that uses psychedelics such as psilocybin as an adjunct to psychotherapy. Some contend that having personal experience with psychedelics is essential to understanding the effects of these substances and being an effective psychedelic therapist, although there are no data that support this contention, psychedelics remain Schedule I controlled substances, and use outside of approved research settings is illegal in the United States, United Kingdom, and elsewhere
Jacob Aday, Ph.D., from the University of California, San Francisco, and co-authors surveyed psychedelic therapists involved in a trial of psilocybin to treat major depressive disorder. The vast majority of the respondents reported personal experience using psychedelic compounds.
More information: Jacob S. Aday et al, Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice, Psychedelic Medicine (2023). DOI: 10.1089/psymed.2022.0004
